{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:29:00Z","timestamp":1761182940750,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development, AMED","doi-asserted-by":"publisher","award":["15fk0108004h0001 and 16fk0108204h0002"],"award-info":[{"award-number":["15fk0108004h0001 and 16fk0108204h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jiac.2017.09.012","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T21:16:37Z","timestamp":1508361397000},"page":"110-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis"],"prefix":"10.1016","volume":"24","author":[{"given":"Hidetoshi","family":"Igari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Futami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizue","family":"Tsuyuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryutaro","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.09.012_bib1","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/ard.2005.047274","article-title":"Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan","volume":"65","author":"Yamada","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jiac.2017.09.012_bib2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.09.012_bib3","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden","volume":"52","author":"Askling","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jiac.2017.09.012_bib4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3899\/jrheum.100623","article-title":"Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"38","author":"Keystone","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jiac.2017.09.012_bib5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infection diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.012_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5588\/ijtld.15.0283","article-title":"Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan","volume":"20","author":"Watanabe","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"year":"2015","series-title":"Guidelines on the management of latent tuberculosis infection","author":"World Health Organization","key":"10.1016\/j.jiac.2017.09.012_bib7"},{"key":"10.1016\/j.jiac.2017.09.012_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.autrev.2008.07.011","article-title":"Screening for tuberculosis infection prior to initiation of anti-TNF therapy","volume":"8","author":"Lalvani","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jiac.2017.09.012_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.09.012_bib10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/rccm.200608-1099OC","article-title":"Comparison of two interferon-\u03b3 assays and tuberculin skin test for tracing tuberculosis contacts","volume":"175","author":"Arend","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.09.012_bib11","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/QAD.0b013e3283188415","article-title":"Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country","volume":"22","author":"Stephan","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2017.09.012_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","article-title":"Routine hospital use of a new commercial whole blood interferon-\u03b3 assay for the diagnosis of tuberculosis infection","volume":"172","author":"Ferrara","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.09.012_bib13","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.5588\/ijtld.16.0038","article-title":"Comparative utility of interferon-\u03b3 release assay, QuantiFERON\u00ae TB-GIT and T-SPOT\u00ae.TB in rheumatoid arthritis","volume":"20","author":"Matsumura","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiac.2017.09.012_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cid\/ciu795","article-title":"Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis","volume":"60","author":"Rozot","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.012_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01976-2016","article-title":"QuantiFERON-TB\u00ae Gold Plus as a potential tuberculosis treatment monitoring tool","volume":"49","author":"Kamada","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2017.09.012_bib16","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load","volume":"187","author":"Day","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jiac.2017.09.012_bib17","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2017.09.012_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/eri.12.150","article-title":"IFN-\u03b3 release assay versus tuberculin skin test for monitoring TB infection in healthcare workers","volume":"11","author":"Nienhaus","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2017.09.012_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","article-title":"Serial testing of health care workers for tuberculosis using interferon-gamma assay","volume":"174","author":"Pai","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.09.012_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1513\/AnnalsATS.201310-378OC","article-title":"IFN-\u03b3 release assay conversions and reversions. Challenges with serial testing in U.S. health care workers","volume":"11","author":"Joshi","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jiac.2017.09.012_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1164\/rccm.201305-0831OC","article-title":"Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers","volume":"188","author":"Slater","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.09.012_bib22","first-page":"84","article-title":"Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States","volume":"19","author":"Joshi","year":"2012","journal-title":"Can Respir J"},{"key":"10.1016\/j.jiac.2017.09.012_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1513\/AnnalsATS.201405-188OC","article-title":"Reproducibility of interferon gamma (IFN-\u03b3) release assays. A systematic review","volume":"11","author":"Tagmouti","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jiac.2017.09.012_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115322","article-title":"Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers","volume":"9","author":"Schablon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2017.09.012_bib25","doi-asserted-by":"crossref","first-page":"30617","DOI":"10.1038\/srep30617","article-title":"Evaluation of QuantiFERON-TB Gold Plus for detection of Mycobacterium tuberculosis infection in Japan","volume":"6","author":"Yi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2017.09.012_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2017.09.012_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2017.09.012_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2017.09.012_bib29","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2169\/internalmedicine.49.3659","article-title":"Impact of peripheral lymphocyte count on the sensitivity of 2 IFN-gamma release assays, QFT-G and ELISPOT, in patients with pulmonary tuberculosis","volume":"49","author":"Komiya","year":"2010","journal-title":"Intern Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17302313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17302313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:07Z","timestamp":1761159427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17302313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1341321X17302313"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.09.012","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}